Kenvue stock drops 10% on report RFK Jr. will link autism to Tylenol use during pregnancy
Kenvue Inc. Tylenol brand Ağrı Savaşıcı was launched on Wednesday, March 27, 2024 at a pharmacy in New York.
Bloomberg | Bloomberg | Getty Images
Shares Kenvue Fell more than 10% on Friday report Robert F. Kennedy Jr., Secretary of Health and Human Services, will connect autism to the use of the company’s painkillers in pregnant women.
The Wall Street Journal said on Friday, HHS will publish a report that can draw this connection this month.
This report will also suggest that a drug derived from the folate can be used to treat symptoms of developmental disorder in some people in a soluble vitamin-inhabitants.
Tylenol may be the most recently used and accepted treatment that Kennedy weakens in the HHS rudder, which controls federal health institutions that regulate drugs and other therapies. Kennedy also took steps to change the vaccine policy in the US and increased false allegations about safe and effective shots using MRNA technology.
In a statement, Kenvue “constantly evaluates science and [continues] Believing that there is no causal connection between the use of acetaminofen, a generic name for Tylenol during pregnancy and autism.
The company, food and pharmaceutical administration and leading medical organizations “agreement on the security of the drug”, the use during pregnancy and the information provided on the Tylenol label, he added.
FDA website The agency says that the use of acetaminophen during pregnancy could not find “open evidence” that “negative pregnancy, birth, neurobavioral or developmental consequences”. However, FDA said that she advised pregnant women to talk to health service providers before using the drugs on the counter.
This is the last minute news. Please refresh for updates.
